Liver Lipocytes, also known as hepatic stellate cells (HSCs) or Ito cells, are specialized cells residing in the liver's sinusoidal space between endothelial cells and hepatocytes. Traditionally recognized for their role in vitamin A storage, these cells are now acknowledged for their dynamic functions in liver physiology and pathology. In response to liver injury or inflammation, quiescent hepatic stellate cells can transform into activated myofibroblast-like cells, contributing to hepatic fibrosis and scar tissue formation. Activated liver lipocytes play a crucial role in the synthesis and deposition of extracellular matrix proteins, such as collagen, leading to tissue remodeling. This fibrotic response can progress to cirrhosis if the underlying cause is not addressed. Beyond their involvement in fibrogenesis, liver lipocytes influence various aspects of liver function, including immune responses and lipid metabolism. Their activation is intricately regulated by multiple signaling pathways, including those involving transforming growth factor-beta (TGF-β) and platelet-derived growth factor (PDGF). Understanding the complex role of liver lipocytes in both normal liver physiology and disease progression is crucial for developing targeted therapeutic strategies to mitigate liver fibrosis and related disorders. Ongoing research aims to uncover novel insights into the molecular mechanisms governing liver lipocyte activation and identify potential therapeutic interventions for hepatic fibrosis.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States